Tortugas Neuroscience Overview

  • Status
  • Private

  • Latest Deal Type
  • Series A

  • Latest Deal Amount
  • $106M

  • Investors
  • 1

Tortugas Neuroscience General Information

Description

Developer of neurological therapeutics intended for the identification of efficacy and impact. The company focuses on identifying and advancing novel drug candidates through a scientific approach that integrates expertise in neurology and neuropsychiatry, enabling patients suffering from brain disorders to access treatments to improve quality of life.

Contact Information

Website
www.tortugasneuro.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 405 Cochituate Road
  • Framingham, MA 01701
  • United States
Primary Industry
Drug Discovery
Vertical(s)
Life Sciences
Corporate Office
  • 405 Cochituate Road
  • Framingham, MA 01701
  • United States

Tortugas Neuroscience Timeline

2023202420252026
Financing Round

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Tortugas Neuroscience Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Early Stage VC (Series A) 16-Apr-2026 $106M Completed Clinical Trials - Phase 2
2. Seed Round 01-Jun-2025 Completed Startup
1. Seed Round 01-Oct-2024 $1M $1M Completed Startup
To view Tortugas Neuroscience’s complete valuation and funding history, request access »

Tortugas Neuroscience Cap Table

Stock # of Shares
Authorized		 Par Value Dividend Rate (%) Original
Issue Price		 Liquidation Liquidation
Pref. Multiple		 Conversion Price % Owned
Series A1
Series A
Seed Prime 6,486,346 $0.000100 $4.63 $4.63 1x $4.63 18.34%
Seed 1,135,000 $0.000100 $1 $1 1x $1 3.21%
To view Tortugas Neuroscience’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Request a free trial

Tortugas Neuroscience Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds
The Column Group Venture Capital Minority
To view Tortugas Neuroscience’s complete investors history, request access »

Ready to get started?

Request a free trial

Tortugas Neuroscience FAQs

  • Where is Tortugas Neuroscience headquartered?

    Tortugas Neuroscience is headquartered in Framingham, MA.

  • What industry is Tortugas Neuroscience in?

    Tortugas Neuroscience’s primary industry is Drug Discovery.

  • Is Tortugas Neuroscience a private or public company?

    Tortugas Neuroscience is a Private company.

  • What is the current valuation of Tortugas Neuroscience?

    The current valuation of Tortugas Neuroscience is .

  • What is Tortugas Neuroscience’s current revenue?

    The current revenue for Tortugas Neuroscience is .

  • How much funding has Tortugas Neuroscience raised over time?

    Tortugas Neuroscience has raised $136M.

  • Who are Tortugas Neuroscience’s investors?

    The Column Group has invested in Tortugas Neuroscience.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process